FDA Brief

Company record

Pico IV Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Pico IV Inc..

Warning letters

  1. Pico IV Inc.

    FDA warned Pico IV Inc. that its intravenous CBD product Pico IV is an unapproved new drug sold with drug claims.

    High risk